Guotai Junan: It is suggested that the beauty care sector with product and channel changes and flexibility should be optimized from the bottom up. Guotai Junan said that after the pressure of consumption in 2022 and the destocking of consumers in 2023, the beauty consumption will return to the normal purchase cycle in 2024, and the industry prosperity will improve month-on-month, and the double-digit growth of online beauty will be achieved. However, after the channel dividend subsided, the platform traffic and price competition became fierce, and the brand differentiation further intensified. Relying on the product innovation and channel operation ability brought by organizational efficiency, the performance of domestic products in the head is still bright, and the rise of new domestic products has spread from beauty cosmetics to personal care. Looking forward to 2025, the market risk appetite will be significantly restored. Because of its many changes and the rising trend of domestic products as a whole, the American nursing sector has obvious growth attributes and significantly benefited from its style. Brand differentiation in the fundamental dimension has intensified, and it is suggested that the flexible target with product and channel changes should be optimized from bottom to top.The American medical insurance giant said that the suspect who assassinated its CEO was not a company customer. A spokesman for UnitedHealth Group said that Luigi Mangione, the suspect accused of killing Brian Thompson, CEO of the company's United Health Care, was not a member of the company's insurance plan. Unitedhealth group said that Man Ghione and his mother were not members of United Health Insurance Company, and refuted the claim that the shooting incident was caused by dissatisfaction caused by his special experience in the company.BlackRock suggested that investors should consider allocating up to 2% in Bitcoin. BlackRock, an asset management company, reported that interested investors are advised to consider allocating up to 2% of their portfolio in Bitcoin. "We believe that investors with proper management ability and risk tolerance have reason to include Bitcoin in multi-asset portfolios," BlackRock's four-member senior management team pointed out in the report. Team members include Samara Cohen, Chief Investment Officer of ETF, and Paul Henderson, Senior Portfolio Strategist of BlackRock Investment Institute.
In the first 11 months of GEM, the scale of raising funds by issuing 34 new shares dropped significantly year-on-year. Statistics show that from January to November, 2024, there were 34 new shares listed on GEM, with a total amount of raised funds of about 20.174 billion yuan. The number of issues and the scale of raising funds decreased by about 67% and 83% respectively year-on-year, and the number of listed new shares declined for three consecutive years. Among them, Nova Nebula and Yilian Technology have raised a total of more than 1 billion yuan, which is on the top. The share prices of the first-time shares of GEM all rose on the first day of listing, among which Changlian Technology and Shangda Shares rose more than 1000% on the first day of listing. In addition, there are 17 new shares listed income increased by more than 200%. In terms of underwriters, in the first November of 2024, the number of main underwriting projects of CITIC Jiantou, Guotai Junan and CICC was in the top three. Judging from the scale of fundraising, the total number of projects underwritten by Minsheng Securities and CITIC Jiantou exceeds 2.5 billion yuan, and the project scale of China Merchants Securities, Huatai United Securities and Guotai Junan exceeds 1.5 billion yuan. (Xinhua Finance)Haitong Securities: The moderate price reduction of traditional Chinese medicine varieties continues. The domestic pharmaceutical industry is expected to set off a wave of mergers and acquisitions. Haitong Securities released a research report saying that the moderate price reduction of traditional Chinese medicine varieties continues. In 2024, the traditional Chinese medicine industry was under pressure due to the pressure of pharmacy terminal sales and inventory pressure, and it is expected to return to a good situation in the next 25 years. In addition, the continuous technological changes in the pharmaceutical industry, the development of IPO to mergers and acquisitions and the promotion of corporate governance optimization at the shareholder level are the main reasons for promoting mergers and acquisitions in the industry. In terms of fields, mergers and acquisitions are expected to occur intensively in sub-sectors such as medical devices, Chinese medicine, medical services, blood products and scientific research services.Thirteen companies disclosed the progress of repurchase, among which Green Energy Huichong and Ruike had the highest amount of laser repurchase plans. On December 13th, a total of 13 companies issued announcements on stock repurchase. Among them, two companies disclosed the stock repurchase plan for the first time, four companies disclosed the progress of the implementation of stock repurchase, and seven companies have completed the implementation of the repurchase plan. Judging from the initial disclosure of the repurchase plan, Green Energy Huichong and Ruike Laser have the highest amount of repurchase plans, with the planned repurchase not exceeding 1.115 million yuan and 487,900 yuan respectively. Judging from the implementation progress of repurchase, Yuanli Technology, Jiuli Special Materials and Jack have the highest share repurchase amounts, with 33.1077 million yuan, 30.9807 million yuan and 3.2323 million yuan respectively. Judging from the completed repurchase, a total of one company repurchased more than 10 million on that day. Aerospace Rainbow, Aerospace Rainbow and Guanshi Technology have completed the highest repurchase amount, with 33.2989 million yuan, 2.479 million yuan and 2.1642 million yuan respectively.
[In November, the global sales of pure electric and plug-in hybrid vehicles exceeded 1.8 million, with China accounting for 70%. According to the data released by market research company Rho Motion on Friday, the global sales of pure electric and plug-in hybrid vehicles increased for the seventh consecutive month in November, with a year-on-year increase of 32.3%, reaching 1.83 million, the third consecutive month reaching a record high. Among them, the sales of pure electric and plug-in hybrid vehicles in China market increased by 50%, reaching 1.27 million vehicles, accounting for nearly 70% of the total global sales.The yield of 10-year active bonds in China inter-bank bond market initially dropped by more than 3 basis points to 1.775% and then hit a record low. The yield of 30-year active bonds in China inter-bank bond market initially dropped by nearly 4 basis points to 2%, also hitting a record low.The Australian stock market fell for the fourth consecutive trading day, led by mining stocks. The Australian stock market fell with the US stock market on Friday, with mining stocks falling the most. The day before, the unemployment rate in Australia fell sharply in November, prompting investors to reduce their bets on interest rate cuts in February. Australia's S&P/ASX 200 index fell 0.7% to 8276.5, the fourth consecutive trading day. The benchmark fell by about 1.6% this week, the biggest weekly decline since early August.
Strategy guide 12-14
Strategy guide 12-14
Strategy guide 12-14
Strategy guide 12-14
Strategy guide
Strategy guide
12-14
Strategy guide 12-14
Strategy guide 12-14
Strategy guide
12-14
Strategy guide
12-14
Strategy guide 12-14